mericitabine

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Hepatitis CHepatitis C, Chronic

Phase 2

A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C

CompletedNCT01482390

Hoffmann-La RocheHepatitis C

Start: 2011-11-30End: 2014-01-31Updated: 2017-04-24

A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C

CompletedNCT01482403

Hoffmann-La RocheHepatitis C, Chronic

Start: 2011-11-30End: 2014-01-31Updated: 2016-08-05

Related Papers

Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies

PLoS ONE2016-01-119 citations